精彩内容糖尿病是我国四大类慢性疾病之一,其并发症还会累及血管、眼、肾、足等多个器官,严重影响患者健康。近几年,中医药防治糖尿病越来越受重视,相关药品市场稳步提升。米内网最新数据显示,2025年Q1-Q3在中国三大终端六大市场,糖尿病中成药的整体销售额暴涨超过10%,广药集团称霸院内外市场,21个独家产品登上两大TOP20品牌榜单,步长制药、倍特药业、健民药业成绩亮眼。今年以来再有3款糖尿病中药新药...
Source Link精彩内容糖尿病是我国四大类慢性疾病之一,其并发症还会累及血管、眼、肾、足等多个器官,严重影响患者健康。近几年,中医药防治糖尿病越来越受重视,相关药品市场稳步提升。米内网最新数据显示,2025年Q1-Q3在中国三大终端六大市场,糖尿病中成药的整体销售额暴涨超过10%,广药集团称霸院内外市场,21个独家产品登上两大TOP20品牌榜单,步长制药、倍特药业、健民药业成绩亮眼。今年以来再有3款糖尿病中药新药...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.